Definitive Healthcare Corp. (NASDAQ:DH) Shares Sold by Stifel Financial Corp

Stifel Financial Corp reduced its stake in Definitive Healthcare Corp. (NASDAQ:DH) by 72.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 16,039 shares of the company’s stock after selling 42,094 shares during the period. Stifel Financial Corp’s holdings in Definitive Healthcare were worth $72,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Massachusetts Financial Services Co. MA raised its position in shares of Definitive Healthcare by 36.8% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 6,053,233 shares of the company’s stock valued at $27,058,000 after purchasing an additional 1,626,813 shares in the last quarter. Millennium Management LLC bought a new stake in Definitive Healthcare during the second quarter worth approximately $9,283,000. Granite Investment Partners LLC lifted its holdings in Definitive Healthcare by 22.5% in the 2nd quarter. Granite Investment Partners LLC now owns 884,872 shares of the company’s stock valued at $4,831,000 after acquiring an additional 162,432 shares during the last quarter. 272 Capital LP bought a new position in shares of Definitive Healthcare in the second quarter valued at $3,480,000. Finally, Victory Capital Management Inc. lifted its holdings in shares of Definitive Healthcare by 6.5% during the third quarter. Victory Capital Management Inc. now owns 542,170 shares of the company’s stock valued at $2,424,000 after purchasing an additional 33,161 shares during the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

Definitive Healthcare Trading Down 2.8 %

DH stock opened at $4.11 on Tuesday. The company has a market cap of $474.80 million, a P/E ratio of -1.33, a PEG ratio of 3.29 and a beta of 1.40. The company has a quick ratio of 2.49, a current ratio of 2.49 and a debt-to-equity ratio of 0.33. Definitive Healthcare Corp. has a twelve month low of $3.19 and a twelve month high of $10.62. The business has a fifty day moving average of $4.38 and a 200-day moving average of $4.61.

Insider Transactions at Definitive Healthcare

In related news, insider William Moschella sold 45,000 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total transaction of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at approximately $2,039,001. This represents a 9.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 14.84% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on DH shares. Needham & Company LLC reissued a “hold” rating on shares of Definitive Healthcare in a research note on Friday, November 8th. Stephens started coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 price objective for the company. Finally, BTIG Research started coverage on Definitive Healthcare in a report on Tuesday, September 17th. They set a “buy” rating and a $7.00 price objective on the stock. One analyst has rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $5.72.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.